No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Powered by MRP Announces Exclusive Agreement with LUVO Medical

To Distribute Aesthetic Devices in the United States

Editor: What To Know

  • MRP founder and CEO Scott Carson stated, “This partnership is an amazing opportunity for Powered by MRP to get LUVO Medical products into the hands of clinicians in the United States for the first time.
  • Io (“MRP”) announced today that it has signed an exclusive agreement with LUVO Medical, headquartered in Ontario, Canada, for the sale and distribution of four LUVO products in the United States –.
  • “With the Bela MD+ Advanced Skin Health Platform being one of the most sought-after products for 2022, this couldn’t have come at a better time for LUVO Medical and MRP.

MRP.io (“MRP”) announced today that it has signed an exclusive agreement with LUVO Medical, headquartered in Ontario, Canada, for the sale and distribution of four LUVO products in the United States – the Bare 808, Bela MD+ Advanced Skin Health Platform, the Darwin and the Lucent IPL.

MRP founder and CEO Scott Carson stated, “This partnership is an amazing opportunity for Powered by MRP to get LUVO Medical products into the hands of clinicians in the United States for the first time.”

Modifying the aesthetics marketplace through successful sales and guarantees of pre-owned equipment, MRP has continued to expand its catalog of new equipment sales and distribution from manufacturers, including its latest venture with LUVO Medical.

“We are thrilled to partner with MRP for the exclusive sale of four LUVO devices in the United States,” said Kevin Noseworthy, VP of Sales at LUVO medical. “With the Bela MD+ Advanced Skin Health Platform being one of the most sought-after products for 2022, this couldn’t have come at a better time for LUVO Medical and MRP.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy